Automate Your Wheel Strategy on ELV
With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELV
- Rev/Share 895.8025
- Book/Share 198.4941
- PB 1.7117
- Debt/Equity 0.7303
- CurrentRatio 0.0
- ROIC 4.7222
- MktCap 75261157090.0
- FreeCF/Share 14.3102
- PFCF 23.7118
- PE 13.2661
- Debt/Assets 0.2638
- DivYield 0.0202
- ROE 0.1301
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ELV | RBC Capital Mkts | Outperform | Sector Perform | -- | $358 | Feb. 3, 2026 |
| Upgrade | ELV | Wolfe Research | Peer Perform | Outperform | -- | $425 | Jan. 8, 2026 |
| Downgrade | ELV | Deutsche Bank | Buy | Hold | -- | $320 | Dec. 19, 2025 |
| Initiation | ELV | Goldman | -- | Neutral | -- | -- | Oct. 14, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | July 21, 2025 |
| Downgrade | ELV | Leerink Partners | Outperform | Market Perform | -- | $310 | July 18, 2025 |
| Downgrade | ELV | Robert W. Baird | Outperform | Neutral | -- | $529 | April 15, 2025 |
| Upgrade | ELV | Argus | Hold | Buy | -- | $450 | March 17, 2025 |
| Downgrade | ELV | Stephens | Overweight | Equal Weight | $520 | $440 | Jan. 22, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Is the Options Market Predicting a Spike in Elevance Health Stock?
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
Read More
Health Insurance Stock Could Rebound Off Historically Bullish Signal
Published: January 29, 2026 by: Schaeffers Research
Sentiment: Neutral
Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn't enough to erase its worst day since March 2020 in the previous session, after the Centers for Medicare & Medicaid Services proposed to raise Medicare Advantage payment rates by only 0.09% in 2027.
Read More
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
Published: January 28, 2026 by: Zacks Investment Research
Sentiment: Positive
ELV tops Q4 EPS estimates as premiums grow and Carelon revenues surge, even as medical membership slips and expenses climb.
Read More
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Published: January 28, 2026 by: Seeking Alpha
Sentiment: Neutral
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Read More
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain
Published: January 28, 2026 by: Seeking Alpha
Sentiment: Negative
Elevance Health, Inc. faces persistent margin and volume pressures, with Q4 operating revenue down 55% YoY and weak 2026 guidance. ELV's benefit expense ratio remains elevated at 90%, with medical inflation and higher utilization driving cost pressures and reduced profitability. Guidance for 2026 anticipates revenue and EPS declines, with adjusted EPS expected to drop 16% and investment income down 15%.
Read More
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say
Published: January 28, 2026 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs
Published: January 27, 2026 by: Seeking Alpha
Sentiment: Negative
U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs
Read More
What Analyst Projections for Key Metrics Reveal About Elevance Health (ELV) Q4 Earnings
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of Elevance Health (ELV) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
Can Elevance Offset Rising Expenses in Q4 With Higher Premiums?
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Neutral
ELV heads into Q4 results with rising premiums and solid revenue growth, but higher expenses and margin pressure could weigh on earnings.
Read More
Earnings Preview: Elevance Health (ELV) Q4 Earnings Expected to Decline
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Negative
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
UNH vs. ELV: Which Managed Care Stock Has the Edge Today?
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health is edging past UnitedHealth as Carelon's growth, strategic exits and a cheaper valuation shape a stronger near-term setup.
Read More
Elevance Health Reflects On The Changed Role of Health Plans
Published: December 12, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are evolving to better support their members in a broader range of situations that affect health. In part.
Read More
Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors
Published: December 08, 2025 by: Seeking Alpha
Sentiment: Positive
Intel (INTC) rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel's x86 central processing units (CPUs) with Nvidia GPUs in AI server systems. Oracle (ORCL) (Information Technology, Systems Software) performed strongly on the continued follow-through following strong quarterly results. Elevance Health (ELV) (Health Care, Managed Health Care) has a high Corporate Resilience Score and is aligned to the Health Access and Innovation theme.
Read More
Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence
Published: December 05, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand their benefits, and find care with confidence. Available through the Sydney Health app and Elevance Health–affiliated health plan websites, Virtual Assistant uses conversational technology to simplify healthcare navigation and improve engagement between members and their health plans. “At Elevance Hea.
Read More
How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service
Published: November 24, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is making healthcare more intuitive and personalized by using technology to simplify access and build trust among health plan members.
Read More
Columbia Contrarian Core Fund Q3 2025 Performance Review
Published: November 18, 2025 by: Seeking Alpha
Sentiment: Negative
The fund underperformed its benchmark, the Russell 1000 Index, during the third quarter. Videogame producer Electronic Art's was the top contributor during the period. Elevance Health was the top underperformer over the period.
Read More
Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings
Published: November 07, 2025 by: MarketBeat
Sentiment: Positive
If you're a parent, you've likely battled with your children over different options at dinner time. What kid wouldn't love to eat hot dogs for dinner every night and then wash it down with a milkshake?
Read More
Elevance Health's Profits Eclipse $1.1 Billion Despite Rising Costs
Published: October 21, 2025 by: Forbes
Sentiment: Positive
Elevance Health Tuesday said third quarter net income rose to nearly $1.2 billion despite rising costs in its government subsidized health insurance plans.
Read More
Elevance Health (ELV) Tops Q3 Earnings and Revenue Estimates
Published: October 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health (ELV) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $4.98 per share. This compares to earnings of $8.37 per share a year ago.
Read More
Elevance beats quarterly profit estimates as medical costs remained in check
Published: October 21, 2025 by: Reuters
Sentiment: Positive
Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check.
Read More
Elevance Health Reports Third Quarter 2025 Results
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2025 results. "Our third quarter results were in line with expectations and reflect disciplined execution across Elevance Health. In a dynamic healthcare environment, we're focused on advancing affordability and elevating the member experience through our growing value-based care partnerships and AI-enabled digital solutions that simplify access and improve outcomes. As we plan for 2026, we remain discipline.
Read More
Wall Street's Insights Into Key Metrics Ahead of Elevance Health (ELV) Q3 Earnings
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Read More
Will Rising Costs Hurt Elevance's Q3 Earnings Despite Higher Premiums?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Negative
ELV's third-quarter earnings may face pressure as rising costs and weaker Medicaid memberships offset premium gains.
Read More
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Negative
Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
Published: October 14, 2025 by: PRNewsWire
Sentiment: Neutral
SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares. Investors who purchased shares of Elevance Health, Inc. (NYSE: ELV) prior to April 2024 and continue to hold any of those NYSE: ELV shares have also certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
Published: September 12, 2025 by: Zacks Investment Research
Sentiment: Positive
ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.
Read More
Is ELV's Push Beyond Insurance a Blueprint for the Healthcare Future?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health expands beyond insurance into primary care, digital health and pharmacy services, aiming to reshape healthcare delivery.
Read More
CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.
Read More
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
Read More
Elevance Health - Piggy Bank Or Headache?
Published: August 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Elevance and peers face earnings pressure from rising medical costs, driven by deferred care, expensive drugs, and persistent medical inflation. The segment has re-rated, and now offers good value. Investor sentiment has returned, and capital is rotating into healthcare.
Read More
About Elevance Health Inc. (ELV)
- IPO Date 2001-10-30
- Website https://www.elevancehealth.com
- Industry Medical - Healthcare Plans
- CEO Gail Koziara Boudreaux
- Employees 104200